Telix Pharmaceuticals Limited Interest Paid Classified As Operating Activities
Telix Pharmaceuticals Limited (TLPPF) reported Interest Paid Classified As Operating Activities of $13.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:InterestPaidClassifiedAsOperatingActivities · last filed 2026-02-20
AUD
| Period end | Interest Paid Classified As Operating Activities 12 month |
|---|---|
| 2024-12-31 | 4.73M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 785.00K AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 408.00K AUD 20-F · filed 2025-02-24 |
USD
| Period end | Interest Paid Classified As Operating Activities 12 month |
|---|---|
| 2025-12-31 | $13.70M 20-F · filed 2026-02-20 |
| 2024-12-31 | $3.09M 20-F · filed 2026-02-20 |
| 2023-12-31 | $385.00K 20-F · filed 2026-02-20 |